GARDEN BIO-CHEM(SZ:300401) Xin Lang Cai Jing·2026-01-08 06:08Core Viewpoint - Garden Biologics has seen a stock price increase of 5.04% on January 8, reaching 16.67 CNY per share, with a trading volume of 648 million CNY and a turnover rate of 7.39%, resulting in a total market capitalization of 9.06 billion CNY [1] Group 1: Company Overview - Zhejiang Garden Biologics Co., Ltd. was established on December 18, 2000, and went public on October 9, 2014 [1] - The company's main business focuses on developing, producing, and selling products related to a complete vitamin D3 industry chain [1] - Revenue composition includes: Vitamin products 47.41%, Pharmaceuticals 30.22%, Lanolin and derivatives 20.93%, Sales of raw materials and others 1.01%, Rental income 0.31%, Other trade products 0.10%, Medical devices 0.01% [1] Group 2: Shareholder Information - Southern Fund's Southern CSI 1000 ETF (512100) is among the top ten circulating shareholders of Garden Biologics, having reduced its holdings by 48,400 shares in the third quarter, now holding 3.4785 million shares, which is 0.65% of the circulating shares [2] - The ETF has generated an estimated floating profit of approximately 2.7828 million CNY today and 2.6089 million CNY during the three-day stock price increase [2] Group 3: Fund Manager Profile - The fund manager of Southern CSI 1000 ETF (512100) is Cui Lei, who has been in the position for 7 years and 64 days [3] - The total asset size of the fund is 122.76 billion CNY, with the best fund return during the tenure being 208.53% and the worst being -15.93% [3]